July 1, 2020Open Access
Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock. A Clinical Trial
Structured PICO
Does angiotensin II improve survival in patients with catecholamine-resistant vasodilatory shock?
P
Population
Patients with Catecholamine-Resistant Vasodilatory Shock (CRVS)
I
Intervention
Angiotensin II
O
Outcome
Survivalhard clinical
Elevated serum renin concentration may identify patients with catecholamine-resistant vasodilatory shock who have a beneficial clinical response to angiotensin II.
Abstract
The serum renin concentration is markedly elevated in CRVS and may identify patients for whom treatment with angiotensin II has a beneficial effect on clinical outcomes.Clinical trial registered with www.clinicaltrials.gov (NCT02338843).